Search Medical Condition
Please enter condition
Please choose location

Komaki Aichi, Japan Clinical Trials

A listing of Komaki Aichi, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (165) clinical trials

Prospective Single-arm Multi Centre Observations Ultimaster Des Registry

All consecutive patients suitable for treatment with DES according to hospital routine practice in centres across the world that agree to participate in the e-ULTIMASTER registry will be treated with Ultimaster DES. Secondary objectives Evaluation of worldwide utilization of DES, Detection of rare events in representative patient population, identification of ...

Phase N/A

0.0 miles

Learn More »

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

The objectives of study are to 1) determine the incidence of adverse events and adverse drug reactions among patients receiving evolocumab for up to 2 years, and 2) identify and describe patient characteristics (e.g. demographics, medical history) associated with the safety and effectiveness of evolocumab therapy for the patients with ...

Phase N/A

1.59 miles

Learn More »

DSJ-2016-07 ATTUNE Cementless CR RP Japan

- Evaluate change from preoperative baseline in post-operative outcomes using additional patient reported measures at 2 years: PKIP (overall and sub-scores), KOOS (overall and sub-scores), AKS and EQ-5D-3L. - Evaluate change from preoperative baseline in pain and satisfaction over time as measured using a modified VAS Pain Score (discrete numbers ...

Phase

3.51 miles

Learn More »

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

This is a randomized (the study medication is assigned by chance), double-blind (neither physician nor participant knows the identity of the assigned treatment), parallel group (each participant group receives different treatments simultaneously), event driven (the study duration is determined by the time taken for a specific number of events to ...

Phase

3.53 miles

Learn More »

ZS Ph2/3 Dose-response Study in Japan

Patients not receiving any therapy for hyperkalemia and with 2 consecutive i-STAT potassium values of ≥ 5.1 mmol/L and ≤ 6.5 mmol/L will be enrolled and randomized 1:1:1 to receive ZS 5 g, ZS 10 g, or placebo TID for 48 hours. Throughout the study most potassium values will be ...

Phase

3.53 miles

Learn More »

CM Asia Nail With AS2 Without AS2 AS2 Study

Objective: To compare fracture reduction maintenance rate at 2-3weeks post-operatively between patients operated with AS2 (investigational group) and patients operated without AS2 (Control group) using same implant system (ZNN CM Asia, Zimmer Biomet). Endpoint: Primary: The rate of reduction position maintenance at 2-3 weeks post-operatively. Secondary: Surgery time / fracture ...

Phase N/A

3.53 miles

Learn More »

This clinical trial is provided by Antidote. Researchers have recently begun testing the idea that patients with early Alzheimer's disease are more likely to benefit from treatment than those with more advanced disease. This study is testing how well a potential new treatment works to reverse the symptoms of early ...

Phase

3.72 miles

Learn More »